Diabetes and the Severity of Pandemic Influenza A (H1N1) Infection
- Robert Allard, MD1,2,3,
- Pascale Leclerc, MSC1,3,
- Claude Tremblay, MSC1 and
- Terry-Nan Tannenbaum, MD1,2
- 1Public Health Department, Montreal Health and Social Services Agency, Montreal, Quebec, Canada;
- 2Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada;
- 3Department of Social and Preventive Medicine, University of Montreal, Montreal, Quebec, Canada.
- Corresponding author: Robert Allard, .
OBJECTIVE To confirm the existence of an increased risk of complications from influenza A (H1N1)p among patients with diabetes.
RESEARCH DESIGN AND METHODS Using data from an enhanced influenza surveillance project in Montreal, Canada, and age/sex-specific population estimates of diabetes prevalence, we estimated the risk of hospitalization among persons with diabetes. Comparing hospitalized patients admitted or not to an intensive care unit (ICU), we estimated the risk of ICU admission associated with diabetes, controlling for other patient characteristics.
RESULTS Among 239 hospitalized patients with PCR-confirmed influenza A (H1N1)p, 162 (68%) were interviewed, of whom 22 had diabetes, when 7.1 were expected (prevalence ratio 3.10 [95% CI 2.04–4.71]). The odds ratio for ICU admission was 4.29 (95% CI 1.29–14.3) among hospitalized patients with diabetes compared to those without.
CONCLUSIONS Diabetes triples the risk of hospitalization after influenza A (H1N1)p and quadruples the risk of ICU admission once hospitalized.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
- Received December 3, 2009.
- Accepted March 18, 2010.
- © 2010 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.